Bank of Montreal’s Evoke Pharma EVOK Stock Holding History

Bank of Montreal’s Portfolio EVOK Stock Details EVOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-69	Closed	-$31K	–	4184
2017 Q1	$31K	Buy	+69	New	+$28.3K	﹤0.01%	3233

Other funds holding EVOK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Precept Management Dallas, Texas $126M AUM 36.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bank of Montreal's EVOK Position: Q2 2017 in Review

Bank of Montreal sold out of Evoke Pharma (EVOK) in Q2 2017, closing a stake of 69 shares — an estimated $31K sold.

Bank of Montreal first reported a position in EVOK in Q1 2017 and held it in 1 quarter. The position peaked at $31K in Q1 2017. 21 funds tracked by Wall St. Rank hold EVOK as of Q2 2017.

Bank of Montreal reported no remaining Evoke Pharma position as of Q2 2017 after selling out during the quarter.
Bank of Montreal sold 69 Evoke Pharma shares in Q2 2017, an estimated $31K.
Bank of Montreal first reported a position in Evoke Pharma in Q1 2017 and held it in 1 quarter.
Bank of Montreal's Evoke Pharma position peaked at $31K in Q1 2017.
21 funds tracked by Wall St. Rank held Evoke Pharma as of Q2 2017.

Based on Bank of Montreal's 13F filing for Q2 2017, filed 11 Jul 2017.